Pure Global
NCT06340113

Mulligan and Mckenzie Exercises Alongwith Stabilization Exercises in Patients With Chronic Neck Pain

Comparison of Mulligan and McKenzie Exercises Along With Stabilization Exercises on Pain, Range of Motion and Disability in Patients With Chronic Neck Pain
Riphah International University·ClinicalTrials.gov·procedureRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Neck Pain
Drug/Device/Intervention
MCKENZIE AND STABILIZATION EXERCISES
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Riphah International University
Location
Lahore, Pakistan
Timeline & enrollment
Phase
N/A
Start date
Nov 20, 2023
End date
Jun 01, 2024
Enrollment
22 participants
Primary outcome

Numeric pain rating scale,Neck Disability Index (NDI),Goniometer

Summary

The goal of this [type of study: Randomized control trial] is to [ compare the effectiveness
 of Mulligan and McKenzie Exercises along with stabilization exercises on pain, range of
 motion and disability ] in [ in patients with chronic neck pain].The main question it aims to
 answer is:
 
 - Wether Mulligan is more effective or Mckenzie exercises along with stabilization
 exercises in the treatment of patients with chronic neck pain Group 1 will recieve
 Mulligan and stabilization exercises Group 2 will recieve Mckenzie and stabilization
 exercises

ICD-10 classifications
Injuries to the neckUnspecified injury of neckMultiple injuries of neckOther and unspecified injuries of neckOther specified injuries of neck
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06340113
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06340113 through Pure Global AI's free database. This phase not specified trial is sponsored by Riphah International University and is currently Recruiting. The study focuses on Neck Pain. Target enrollment is 22 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.